<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Regression of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> may occur after effective anti-reflux surgery </plain></SENT>
<SENT sid="1" pm="."><plain>Roux-en-Y gastric bypass (RYGBP) is an effective operation to treat morbid <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, it provides complete relief of <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Regression of Barrett's has not been reported after RYGBP </plain></SENT>
<SENT sid="4" pm="."><plain>We performed a laparoscopic Roux-en-Y gastric bypass on a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>At 1 year after the RYGBP, an upper endoscopy was performed as routine surveillance for the patient's <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>; endoscopic and histologic evaluation demonstrated complete regression of the <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The patient lost one-third of her preoperative weight and had resolution of her reflux symptoms </plain></SENT>
<SENT sid="7" pm="."><plain>RYGBP limits the amount of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> and completely diverts bile away from the esophagus </plain></SENT>
<SENT sid="8" pm="."><plain>This may lead to the regression of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>